ANIMATION

Bavituximab Mechanism of Action (MOA)

Share this animation:

Together with Peregrine, we helped depict the mechanism of action behind Bavituximab, an investigational treatment that helps the body recognize cancer cells. Upregulated expression of phosphatidylserine by cancer cells contributes to their ability to avoid destruction by the immune system. Bavituximab targets phosphatidylserine, thereby encouraging active immune activity in cancerous environments.

Share It:
Contact XVIVO

Client


Peregrine Pharmaceuticals, Inc.

My experience working with XVIVO can be summed up in one word: Confidence. Confidence in the depth of scientific knowledge they contributed, this knowledge only enhanced the end product, was evident as a core competency from our initial discussions even before engaging them for the production, and inspired our team because they were collaborating with a partner who is as dedicated to the science of the story as they are.

VP, Director of Production, JUICE Pharma Advertising
Share this animation: